SCOLR Pharma oral ibuprofen wins European patent
The oral modified release ibuprofen formulation is based on the company’s CDT controlled delivery technology platform, designed for the programmed release of active pharmaceutical ingredients and nutritional products.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.